American Evaluation Association

Slides:



Advertisements
Similar presentations
Breast Cancer Research Program
Advertisements

How to contact us Scottish Mental Health Research Network “Facilitating the development, set up and successful completion of mental health clinical research.
Restructuring the Cancer Programs and Task Force Workgroups.
What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.
NBSTRN Update NCC/RC PI/PD Meeting November 19, 2010 Michael Watson.
EVIDENCE BASED HEALTH CARE and BEST PRACTICES at Northwestern Health Sciences University Gert Bronfort DC, PhD; Michele Maiers, DC, MPH; Roni Evans DC,
Welcome to the Montana Cancer Control Coalition (MTCCC)
The National Comprehensive Cancer Control Program (NCCCP): Current Progress and Future Action Temeika L. Fairley, Epidemiologist Comprehensive Cancer Control.
Influencing Change in Research, Treatment Protocols, and New Drug Development.
NCI Center for Global Health Jo Anne Zujewski, M.D. September 11, 2014 Dar es Salaam, Tanzania.
American Evaluation Association EVALUATION 2011 November 3, 2011 Approaches to Biomedical Research and Development Portfolio Analysis: Examples From the.
Working Plan of US-China Bilateral cooperation on biomedical data sharing.
Overview of All SEER-Medicare Publications Through 2012 Mark D. Danese, MHS, PhD July 24, 2012.
Multnomah County Health Department ►Essential Services ►FDA Food Standards ►PACE Tools for Food Program Excellence Lila Wickham March 17, 2004 ♣
Claire Brindis, Dr. P.H. University of California, San Francisco American Public Health Association- Annual Meeting November 10, 2004 Adolescent Health:
Unlocking the Power of NHANES. Agenda I.Introduction Joshua Murphy, Vice President II.Demonstration/Training Dennis Wijnker, Senior Software Architect,
Connecting South Carolina: The Gibbs/Hollings Cancer Center An NCCCP/NCI Designated Center Connection Anita L. Harrison, MPH Associate Director, Administration.
American Evaluation Association EVALUATION 2009 November 14, 2009 Building Data Systems to Support Evaluation in a Biomedical Research and Development.
Igniting our potential Health Research Classification System Dr. Ian Viney Medical Research Council (MRC) Director of Strategic Evaluation and Impact MRC.
HIV/AIDS Research and Service Activities: Department of Epidemiology and Biostatistics, GWU SPHHS Alan E. Greenberg Manya Magnus Irene Kuo Amanda Castel.
Evaluating the impact of health research: Revisiting the Canadian Institutes of Health Research Impact Assessment Framework Nicola Lauzon, Marc Turcotte.
Systems Approaches to Population Health. Activities Supported by NCI.
Why a CPCRN? CDC Expectations Katherine M. Wilson, PhD, MPH CPCRN Technical Monitor Division of Cancer Prevention and Control CDC.
Catalogue of Surveillance Systems: Introduction Webinar May 5, 2011 Susan M. Krebs-Smith, PhD National Cancer Institute, National Institutes of Health.
Breast Cancer Surveillance Consortium: Progress in Understanding Screening Delivery and Early Detection Rachel Ballard-Barbash, MD, MPH, Associate Director,
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Massachusetts Cancer Prevention Community Research Network (MCPCRN) CPCRN Atlanta Meeting October 15-16, 2009.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
Land Degradation Assessment in Drylands Riccardo Biancalani FAO LADA Team Mendoza, 26 January 2009.
Evaluating Training and Career Development Grants in the Biomedical Sciences: Methods, Measures, Benchmarks, & Best Practices.
What does the cancer intelligence landscape look like now? Dr Mick Peake Clinical Lead, National Cancer Intelligence Network.
Organizational Funding Portfolios and Beyond: Assessing the Full Research Landscape Panel Session 731 American Evaluation Association EVALUATION 2012 October.
Vincent HabiyambereGuillermo Lopez Rozada PSM Toolbox Update.
David M. Murray, Ph.D. Associate Director for Prevention Director, Office of Disease Prevention Multilevel Intervention Research Methodology September.
Assessment of Proposed Research: National Cancer Institute Provocative Questions Initiative Case Study Elizabeth Hsu American Evaluation Association 2012.
How To Build An Assessment And Impact Model Dr. Suzan Harkness
ROTARY GRANTS.
Samantha Finstad, Ph.D.* National Cancer Institute Lynne Davies, Ph.D.
Ruth Geraghty Data Curator Children’s Research Network
Global Coordination Platform
Translational Research Methodology
Knowledge Informatics
Kari Wojtanik, Ph.D. Susan G. Komen Samantha Finstad, Ph.D.
NCD in Bulgaria Assoc. Prof. Plamen Dimitrov, MD, PhD
Kari Wojtanik, Ph.D. Susan G. Komen Samantha Finstad, Ph.D.
Evaluation of NCI Research Resources
Global Coordination Platform
Carly Green, MGD Component Manager
The Influence of Domain-Specific Metric Development on Evaluation and Design: An Example from National Institutes of Health Technology Development Programs.
The GEO-6 Matrix Drafting Approach
Global Coordination Platform
Senaida Poole, Ph.D. California Breast Cancer Research Program
Dr Joe McNamara Head of Population Health Sciences MRC
“How Can Providers Address the Lack of R01 Studies. ” Robert H
Department of Medicine Michael Farkouh, Vice-Chair Research michael
Goals and Expected Outcomes: Strategies Driving Collaboration:
Ruth Geraghty Data Curator Children’s Research Network
Evaluation Activities
UK Health Research Analysis
High Value Care– What’s Needed?
Prevention Fund Allocations – (Fiscal Year 2016)
Experimental Medicine Challenge Grants Round 3
COST and COST Actions Participation of Georgian researchers
Goals and Expected Outcomes: Strategies Driving Collaboration:
What is FASEB? A federation of 30 societies
Dr Timothy Armstrong Coordinator
Partnership for Research and Innovation in the Health System (PRIHS) /2020 Sean Dewitt, Program Manager, Health, Alberta Innovates Marc Leduc,
Indiana Traumatic Brain Injury State Plan 2018 – 2023
PICTURE HERE Eric Chokunonga Zimbabwe Cancer Registry On behalf of:
OFFICE OF EQUITY AND DIVERSITY
Presentation transcript:

American Evaluation Association The International Cancer Research Partnership: A Global Collaboration Enabling Analyses of Sponsor-Funded Cancer Research Panel Session 2549 American Evaluation Association EVALUATION 2015 November 11, 2015

Kari Wojtanik and Lynne Davies Session Presenters Elizabeth Hsu Session Chair Miranda Kleijn Translational Research: Monitoring Trends in the International Cancer Portfolio Senaida Poole Prevention Research: Utilizing a Global Database to Identify and Act on Trends in Research Funding Kari Wojtanik and Lynne Davies Global Assessment of Funding Trends Across a Diverse Spectrum of Issues in Breast Cancer Research Samantha Finstad Assessment of the International Cancer Research Partnership Lung Cancer Portfolio

ICRP: adding value to cancer research ICRP’s mission is to add value to cancer research efforts internationally by fostering collaboration and strategic co-ordination between cancer research organizations. Mission www.icrpartnership.org ICRP Chair 2015-2017: Dr. Miranda Kleijn Vice-Chair: Dr. Katie McKenzie

History & milestones 2000 Cancer “CSO” classification tool developed by NCI & CDMRP 8 organizations invited to join 2003 First generation website launched 2010 Agreement to share full data between Partners 2011 New website launched to Partners, giving access to improved analytical tools 2012 Public launch of new ICRP site First international analysis of cancer research (2005-2008) published 2015 Data from 109 organizations included in the ICRP database Planned launch of 2nd International analysis of cancer research (2005+) Brief history & milestones

Who is involved? Coalition against Childhood Cancer & Cancer Institute NSW new in 2015

ICRP Coding and Database Participating organizations/agencies share high quality, coded data The ICRP database contains data on more than 76,000 grants from 109 organizations (> $6bn p.a.) and is expanding every month. We use this unique resource to ask: What are the gaps in cancer research? What are the trends in cancer research funding? What types of projects have been funded (e.g. clinical, research, training)? What research areas are being funded (CSO)? What types of cancer are being funded? What is the funding profile across different countries and organizations? How can we maximize our research efforts? How can we foster strategic collaborations between funding organizations? What we do – data No. of orgs correct as of 1 April 2014 https://www.icrpartnership.org/database.cfm

Common Scientific Outline (CSO) (ver 2) 1. Biology 1.1 Normal functioning 1.2 Chromosome alterations 1.3 Oncogenes and tumor suppressor genes 1.4 Progression and metastasis 1.5 Resources and infrastructure 2. Etiology 2.1 Exogenous factors 2.2 Endogenous factors 2.3 Interactions 2.4 Resources and infrastructure 3. Prevention 3.1 Behavior interventions 3.2 Dietary interventions 3.3 Chemoprevention 3.4 Vaccines 3.5 Complementary and alternative approaches 3.6 Resources and infrastructure 4. Early detection, diagnosis and prognosis 4.1 Development and discovery 4.2 Evaluation 4.3 Testing in clinical setting 4.4 Resources and infrastructure 5. Treatment 5.1 Localized - Development 5.2 Localized - Clinical 5.3 Systemic - Development 5.4 Systemic - Clinical 5.5 Localized + Systemic 5.6 Complementary and alternative approaches 5.7 Resources and infrastructure 6. Control, survivorship, outcome 6.1 Care and survivorship 6.2 Surveillance 6.3 Behavior 6.4 Health services 6.5 Education 6.6 End-of-life care 6.7 Ethics 6.9 Resources and infrastructure CSO v2 released in April 2015. Coding modified to adapt to evolution in science/research, and learned from strengths/weaknesses of version 1. Further details on this will be given in the prevention presentation. https://www.icrpartnership.org/CSO.cfm

Cancer Site Codes 47 cancer site codes 9 ‘roll up’ codes (e.g., urinary cancers, blood cancers) Coded with a “percent relevance” to the site; may sum to more than 100%

Enables structured searches of 1000s of awards Comprehensive search functionality Users can search by year, organization, city, country, CSO, cancer type, keyword, project type, PI Name….

ICRP: data at the touch of a button Lung cancer research by CSO code, internationally Oesophageal cancer research in the UK

Understanding the cancer research landscape ICRP publishes regular data reports 2005-2008 benchmark analysis of cancer research funding 2005-2012 trend analysis of international cancer research (publication due in 2015) ICRP data contributes to topic-specific reports led by ICRP or partner organizations Recent ICRP publications: Obesity & cancer (2014) Environmental influences on breast cancer (2014) Metastatic breast cancer (2014) How data helps – ICRP report (2005-2008 data), included in other reports too https://www.icrpartnership.org/publications.cfm

Enabling Cross-Funder Multinational Analyses All grants submitted to the ICRP database are classified by CSO “Type of research” Cancer site “Type of cancer” ICRP partners and staff are also developing new tools and methodologies to mine this dataset in more detail Cross-cutting analysis using keywords, boolean searches Extracting award data and adding meta-data through a combination of semi-automated and manual coding Investigating new tools in partnership with others to add value to the data Case studies presented today: Translational research: monitoring trends in the international cancer portfolio Prevention research: Utilizing a global database to identify and act on trends in research funding Global assessment of funding trends across a diverse spectrum of issues in breast cancer research Assessment of the International Cancer Research Partnership lung cancer portfolio